mani
viral
infect
prevent
immun
live
attenu
vaccin
earli
method
attenu
hitandmiss
much
improv
genet
engin
even
current
attenu
method
oper
principl
genet
harm
reduc
viru
abil
grow
turn
limit
host
immun
respons
infect
wildtyp
use
mathemat
model
dynam
viru
control
innat
adapt
immun
explor
tradeoff
attenu
viru
growth
gener
immun
analysi
suggest
direct
attenu
disabl
key
viral
defens
host
immun
respons
may
attenu
viral
growth
without
compromis
potenti
even
enhanc
gener
immun
explor
immun
evas
pathway
attenu
attenu
multipl
pathway
could
lead
robust
attenu
patholog
enhanc
immun
mani
highli
success
viral
vaccin
use
live
attenu
virus
typic
variant
wildtyp
viru
genet
reduc
capac
grow
attenu
vaccin
consid
offer
superior
protect
type
vaccin
earli
method
attenu
haphazard
reli
adapt
viral
growth
unnatur
artifici
condit
indirectli
evolv
viru
reduc
capac
grow
natur
host
fact
attenu
larg
blind
method
repeat
suggest
broad
window
viral
growth
reduct
compat
practic
vaccin
attenu
viral
attenu
enter
new
era
genet
engin
becam
possibl
achiev
quantit
reduct
viral
growth
rate
block
evolutionari
revers
attenu
much
guesswork
reduc
viral
growth
rate
elimin
genet
engin
approach
engin
likewis
slow
block
vaccin
abil
revers
chang
becom
virul
genet
engin
may
usher
third
era
one
attenu
design
enhanc
immun
respons
direct
attenu
requir
genet
alter
engin
viru
manner
reduc
patholog
enhanc
level
protect
immun
paper
use
term
direct
attenu
refer
engin
viral
genom
influenc
level
immun
need
new
method
viral
attenu
necessarili
obviou
mani
attenu
vaccin
use
creat
old
method
brought
dramat
reduct
preval
infect
side
effect
anyth
gain
chang
design
howev
live
attenu
vaccin
typic
elicit
much
immun
natur
infect
potenti
result
reinfect
circul
viru
eg
mump
necessit
period
boost
furthermor
fundament
level
vaccin
remain
elus
mani
virus
requir
explor
altern
approach
vaccin
design
trivial
matter
engin
live
vaccin
knowingli
vari
immun
respons
becom
practic
engin
viru
knowingli
reduc
patholog
ie
attenu
howev
current
attenu
compromis
growth
viru
lead
reduc
viremia
typic
elicit
smaller
immun
respons
issu
attenu
growth
viru
without
compromis
long
term
immun
perhap
even
elev
requir
understand
complex
interact
feedback
viru
growth
gener
adapt
immun
first
step
involv
character
differ
viral
protein
interact
cell
molecul
involv
gener
immun
respons
subject
recent
advanc
molecular
cellular
virolog
immunolog
review
yet
qualit
understand
pathway
enough
nonlinear
feedback
viru
growth
immun
make
hard
comprehend
effect
modifi
viral
gene
protein
level
immun
gener
direct
attenu
enhanc
immun
without
increas
patholog
clear
possibl
target
pathway
interfer
host
immun
may
simpli
result
rapid
viru
clearanc
less
patholog
consequ
less
clonal
expans
immun
end
infect
approach
direct
attenu
present
develop
mathemat
model
incorpor
key
element
current
understand
replic
viru
immun
respons
elicit
use
model
explor
whether
direct
attenu
might
simultan
reduc
patholog
enhanc
immun
identifi
candid
pathway
viru
engin
use
deliber
simpl
model
dynam
infect
viru
liveattenu
vaccin
let
v
equal
viru
densiti
z
x
equal
magnitud
innat
adapt
respons
respect
function
time
viru
grow
exponenti
rate
r
absenc
innat
adapt
immun
viru
kill
innat
adapt
immun
rate
proport
current
immun
level
paramet
k
z
k
x
respect
innat
immun
z
activ
infect
satur
z
equal
fraction
maximum
valu
innat
immun
adapt
immun
x
grow
proport
innat
immun
z
represent
modif
usual
use
stimul
adapt
immun
depend
amount
viru
v
justifi
biolog
ground
gener
immun
respons
requir
stimul
innat
immun
occur
even
replic
antigen
clear
let
extent
patholog
p
equal
maximum
level
viru
basic
form
similar
use
previous
model
intend
captur
basic
properti
immun
respons
help
discov
unintuit
interact
feedback
effect
aris
consequ
viral
growth
interfer
host
immun
respons
model
pretend
paramet
descript
valu
rang
r
viru
growth
rate
innat
immun
z
rate
activ
innat
immun
v
sensit
innat
immun
kill
viru
innat
immun
adapt
immun
x
rate
activ
adapt
immun
z
sensit
adapt
immun
k
z
kill
viru
adapt
immun
xd
captur
known
complex
mammalian
immun
system
exampl
includ
differ
popul
innat
immun
cell
cytokin
gener
immun
respons
inclus
detail
stage
would
lead
complex
model
hope
parameter
situat
simpl
model
often
robust
perform
better
complex
one
dynam
acut
infect
straightforward
fig
show
chang
viral
titer
innat
adapt
immun
cours
infect
viru
initi
grow
exponenti
soon
thereaft
innat
immun
system
trigger
begin
limit
viral
growth
innat
immun
temporari
decay
zero
viru
clear
adapt
immun
respons
somewhat
delay
rel
innat
immun
respons
clearanc
infect
subsequ
maintain
focus
gener
adapt
immun
viru
consid
subsequ
wane
immun
stage
origin
approach
attenu
viru
grow
unnatur
condit
eg
novel
host
cell
cultur
adapt
unnatur
condit
often
unpredict
reduc
growth
rate
primari
host
human
consequ
loss
pathogenesi
newer
method
engin
attenu
also
lower
viral
growth
rate
far
predict
viral
growth
rate
less
wildtyp
atten
fection
viru
v
shown
red
innat
immun
z
black
adapt
immun
x
blue
scale
viru
immun
fold
chang
initi
valu
v
x
set
scale
innat
immun
percent
maximum
possibl
valu
simul
z
attain
maximum
paramet
chosen
biolog
relev
regim
describ
earlier
shown
tabl
uat
viru
attain
smaller
peak
densiti
clearanc
thu
elicit
less
adapt
immun
wit
singl
infect
wildtyp
measl
mump
rubella
virus
typic
induc
lifelong
immun
vaccineinduc
immun
frequent
requir
boost
indic
cdc
immun
schedul
basic
tradeoff
provid
baselin
reproduc
reason
model
viralimmun
dynam
reduc
viral
growth
rate
result
reduc
viral
densiti
clearanc
reduc
pathogenesi
consequ
reduc
stimul
adapt
immun
lower
final
level
adapt
immun
model
inde
gener
expect
pattern
fig
pattern
highlight
fundament
question
studi
possibl
engin
attenu
better
achiev
mere
reduc
viral
growth
rate
arrang
pathogenesi
go
immun
go
approach
question
involv
vari
viruseffect
paramet
observ
chang
pathogenesi
immun
done
next
virus
pathway
interfer
innat
adapt
immun
respons
reduc
magnitud
effect
immun
candid
pathway
target
could
lead
increas
immun
model
suppress
viral
pathway
chang
paramet
correspond
attenu
strategi
reduc
pathogenesi
tabl
note
suppress
viral
pathway
may
result
increas
paramet
valu
occur
wildtyp
viru
depress
host
antivir
respons
viru
strategi
evad
innat
immun
model
low
valu
z
maximum
rate
stimul
high
valu
v
level
viru
need
stimul
high
valu
z
decay
rate
innat
immun
similarli
virus
avoid
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
dash
dot
indic
attenu
reduc
viru
growth
rate
result
lower
viremia
well
reduct
level
immun
dynam
wildtyp
infect
solid
line
red
viru
blue
immun
virus
dash
reduc
growth
rate
dot
b
impact
degre
attenu
reduct
r
final
level
immun
blue
patholog
maximum
viru
densiti
red
c
tradeoff
patholog
immun
chang
growth
rate
r
reduc
growth
rate
result
lower
patholog
also
lower
immun
paramet
tabl
ulat
adapt
immun
low
valu
x
maximum
rate
prolifer
immun
cell
high
valu
z
level
stimul
requir
induc
prolifer
adapt
immun
cell
virus
also
limit
kill
innat
adapt
immun
low
valu
rate
constant
k
z
k
x
respect
attenu
thu
involv
chang
paramet
opposit
direct
reduc
patholog
interest
also
lie
chang
addit
effect
increas
final
level
adapt
immun
least
lower
adapt
immun
max
rate
clonal
expans
x
decreas
increas
sensit
immun
antigen
z
decreas
increas
kill
adapt
immun
k
x
decreas
decreas
tabl
candid
direct
attenu
summari
direct
attenu
aris
chang
singl
paramet
desir
outcom
result
decreas
patholog
increas
immun
shown
boldfac
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
parasit
paramet
affect
adapt
immun
x
block
immuneevas
gene
attenu
infect
chang
also
enhanc
immun
block
reduc
viral
immuneevas
pathway
lead
attenu
viru
fig
thu
potenti
rout
gener
live
attenu
viru
vaccin
might
chang
affect
level
immun
block
pathway
make
viru
sensit
clearanc
either
innat
k
z
adapt
k
x
immun
result
rapid
control
viru
lower
final
level
immun
contrast
block
pathway
slow
gener
adapt
immun
either
chang
immun
growth
rate
x
sensit
adapt
immun
z
result
greater
stimul
higher
final
level
adapt
immun
final
suppress
viral
pathway
acceler
innat
immun
decay
z
prolong
stimul
adapt
immun
increas
final
level
thu
attenu
modifi
immuneevas
pathway
describ
paramet
x
z
z
gener
hopedfor
outcom
reduc
patholog
increas
immun
attenu
immuneevas
pathway
associ
chang
stimul
innat
immun
z
v
suscept
kill
innat
adapt
immun
k
z
k
x
result
higher
immun
detail
consider
effect
chang
paramet
dynam
infect
immun
consid
supplement
file
pathologyimmun
plot
enabl
easi
comparison
attenu
strategi
effect
differ
attenu
pathway
may
directli
compar
plot
togeth
grid
patholog
immun
fig
ideal
live
attenu
viru
vaccin
would
gener
lower
patholog
higher
immun
infect
wildtyp
viru
correspond
upper
left
quadrant
wildtyp
taken
center
straightforward
see
direct
attenu
work
three
paramet
identifi
z
x
z
also
seen
increas
sensit
innat
immun
decreas
v
lead
attenu
patholog
without
compromis
immun
summari
success
direct
attenu
strategi
singl
paramet
chang
given
tabl
two
potenti
problem
direct
attenu
singl
viral
antiimmun
pathway
revers
consequ
vaccin
immunocompromis
individu
discuss
later
revers
may
signific
problem
focu
inadvert
vaccin
immunocompromis
individu
problem
especi
appar
viru
attenu
delet
antivir
strategi
target
defens
pathway
lack
patient
classic
method
attenu
compromis
growth
viru
reduc
growth
rate
r
avoid
problem
least
make
infect
less
sever
wildtyp
viru
howev
individu
overcom
prob
comparison
immunitypatholog
tradeoff
gener
chang
singl
paramet
wildtyp
valu
given
intersect
curv
viabl
attenu
strategi
would
lie
left
goal
attenu
increas
immun
respons
desir
attenu
strategi
lie
upper
left
quadrant
tradeoff
classic
mode
attenu
lower
growth
rate
r
black
line
undesir
effect
lower
immun
contrast
decreas
rate
loss
innat
immun
z
increas
rate
prolifer
sensit
adapt
immun
x
red
z
blue
lead
lower
patholog
increas
immun
lem
direct
attenu
could
use
combin
strategi
one
type
combin
block
immun
evas
separ
reduc
growth
rate
anoth
type
combin
block
evas
adapt
immun
evas
innat
immun
worri
combin
strategi
reduc
immun
might
sever
wildtyp
immun
attain
viru
classic
growth
rate
reduct
antiimmun
defens
also
disabl
answer
appear
affirm
combin
fig
top
four
panel
show
effect
reduc
viral
growth
rate
go
right
left
horizont
axi
effect
chang
one
immun
paramet
suppress
immuneevas
pathway
chang
sensit
adapt
immun
reduc
z
decay
rate
innat
immun
ie
increas
z
restor
vaccin
immun
level
elicit
wildtyp
viru
right
column
done
without
compromis
level
attenu
pathogenesi
obtain
reduct
r
left
column
combin
possibl
without
alter
growth
rate
r
combin
may
likewis
result
reduc
patholog
enhanc
immun
fig
combin
shown
chang
growth
rate
bottom
row
suppress
viral
evas
innat
immun
increas
v
sensit
adapt
immun
stimul
innat
immun
increas
z
one
strike
observ
fig
effect
vari
paramet
substanti
differ
case
top
row
immun
chang
respons
paramet
patholog
chang
larg
respons
growth
rate
r
bottom
row
immun
strongli
affect
sensit
adapt
respons
z
larg
unaffect
sensit
innat
immun
respons
v
wherea
patholog
show
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
effect
chang
growth
rate
paramet
goal
patholog
becom
increasingli
blue
immun
becom
increasingli
red
travers
wildtyp
vaccin
classic
attenu
strategi
aris
reduct
singl
paramet
r
seen
reduc
patholog
immun
move
left
along
horizont
axi
top
four
panel
howev
combin
reduct
r
increas
sensit
adapt
immun
respons
ie
decreas
z
increas
durat
innat
immun
ie
increas
z
restor
level
immun
gener
vaccin
induc
wildtyp
viru
top
two
row
bottom
row
show
ideal
attenu
achiev
chang
pair
paramet
includ
r
much
opposit
pattern
middl
row
show
patholog
immun
affect
combin
paramet
valu
result
reinforc
unintuit
natur
direct
attenu
illustr
model
use
tool
understand
consequ
nonlinear
feedback
differ
vaccin
strategi
attenu
vaccin
mainstay
viral
vaccin
close
centuri
attenu
typic
interpret
genet
reduct
viral
growth
rate
reduc
abil
grow
host
outcom
easili
achiev
almost
disrupt
modif
viral
genom
advanc
genet
engin
enabl
attenu
design
previous
unattain
even
tend
mode
disrupt
viral
growth
suggest
extend
approach
attenu
one
direct
viru
toward
reduc
defens
host
immun
approach
attenu
suggest
fact
mani
virus
directli
interfer
immun
respons
interfer
gene
obviou
target
genet
engin
target
viral
immuneevas
pathway
compromis
viral
load
gener
result
reduct
patholog
howev
unlik
reduc
viru
growth
rate
reduc
patholog
also
reduc
immun
respons
direct
attenu
might
instead
increas
immun
respons
use
simpl
comput
model
immun
respons
viral
infect
inde
find
disrupt
viral
antiimmun
respons
attain
desir
goal
reduc
patholog
without
compromis
gener
immun
model
allow
us
identifi
characterist
immuneevas
pathway
target
achiev
desir
outcom
chang
one
paramet
model
allow
us
explor
consequ
target
multipl
viru
pathway
suggest
attenu
design
includ
reduc
viral
growth
rate
togeth
disabl
care
chosen
immuneevas
pathway
would
ideal
could
provid
enhanc
immun
compar
natur
infect
along
reduc
patholog
even
immunecompromis
individu
focus
viru
pathway
compromis
magnitud
immun
respons
similar
principl
could
appli
viru
pathway
compromis
mainten
memori
could
also
extend
inactiv
viru
vaccin
genet
engin
remov
gene
viru
protein
inhibit
gener
immun
respons
may
protein
function
absenc
viru
replic
enhanc
immun
respons
elicit
vaccin
kill
viru
exampl
immun
evas
strategi
much
genom
encod
immuneevas
pathway
pathway
target
host
type
interferon
tumor
necrosi
factor
complement
pathway
innat
immun
also
evad
adapt
immun
downregul
antigen
present
block
costimulatori
pathway
apoptot
respons
adenovirus
mediums
nonenvelop
virus
contain
doubl
strand
dna
genom
encod
immuneevas
pathway
inhibit
tumor
necrosi
factor
activ
also
evad
adapt
immun
downregul
antigen
present
one
best
studi
immuneevas
gene
protein
influenza
viru
major
function
protein
interfer
multipl
stage
type
interferon
signal
cascad
mutant
influenza
viru
lack
protein
highli
attenu
wildtyp
interferoncompet
mice
ifnincompet
system
stat
knockout
mice
virus
truncat
delet
gene
shown
promis
candid
live
attenu
vaccin
chicken
type
interferon
play
role
reduc
viru
replic
correspond
decreas
growth
rate
viru
r
model
without
chang
paramet
govern
gener
immun
respons
chang
paramet
r
model
result
less
patholog
smaller
immun
respons
consist
outcom
experiment
infect
chicken
influenza
viru
vaccin
delet
protein
suggest
might
worth
explor
possibl
target
viru
immuneevas
pathway
immun
respons
increas
result
base
simpl
model
withinhost
dynam
viru
immun
acut
infect
appli
model
specif
virus
requir
incorpor
detail
particular
viru
evad
immun
respons
well
relev
compon
immun
respons
elicit
viru
select
appropri
immuneevas
pathway
certainli
requir
experiment
studi
experi
would
along
line
studi
delet
influenza
viru
discuss
earlier
first
step
would
gener
potenti
vaccin
virus
attenu
differ
immuneevas
gene
ideal
grade
manner
vaccin
candid
would
use
infect
anim
allow
quantif
differ
attenu
strategi
affect
dynam
viru
patholog
gener
immun
respons
intuit
consequ
differ
mutat
challeng
nonlinear
feedback
control
viru
gener
host
immun
consequ
model
incorpor
relev
detail
specif
viru
immuneevas
pathway
may
help
suggest
combin
pathway
target
analysi
result
turn
allow
refin
model
basic
engin
level
suggest
addit
compromis
viru
immuneevas
gene
eg
knockout
codon
deoptim
direct
attenu
involv
upregul
addit
gene
enhanc
gener
immun
candid
upregul
addit
includ
pathogen
associ
molecular
pattern
pamp
induc
appropri
form
immun
studi
surrog
protect
could
help
identifi
appropri
pamp
inclus
viru
one
consider
possibl
viru
revers
gene
addit
like
prone
revers
delet
point
mutat
gene
delet
howev
ie
suggest
withinhost
vaccin
evolut
compromis
vaccin
immun
extent
evolut
vaccin
manufactur
sever
evolut
may
avoid
mitig
suitabl
choic
vaccin
inoculum
intent
use
simpl
model
illustr
potenti
direct
attenu
strategi
develop
vaccin
particular
viru
evas
mechan
would
requir
model
tailor
relev
detail
gener
one
complex
gener
model
unrealist
intract
current
time
empir
complex
includ
consid
relev
detail
particular
viru
least
virus
small
genom
gene
antiimmun
function
may
pleiotrop
effect
may
challeng
engin
retain
potenti
essenti
function
disrupt
antiimmun
function
pleiotrop
effect
result
disrupt
immuneevas
pathway
could
incorpor
model
allow
chang
one
term
paramet
current
model
would
need
extend
includ
scenario
extent
attenu
describ
chang
relev
paramet
depend
viru
densiti
suggest
nonselfish
viru
evas
strategi
current
model
immun
includ
differ
branch
eg
humor
cellular
complex
differenti
pathway
gener
immunolog
memori
elabor
model
warrant
elabor
base
detail
consider
vaccin
scenario
specif
viru
simpl
model
omit
mani
detail
advantag
often
robust
highli
complex
one
current
model
incorpor
feedback
viral
defens
immun
respons
may
key
properti
relev
direct
attenu
summari
studi
use
model
explor
consequ
attenu
viru
target
interact
viru
host
immun
respons
rather
tradit
approach
target
viral
growth
rate
approach
allow
us
explor
new
vaccin
may
design
goal
maxim
level
protect
immun
gener
contrari
convent
view
possibl
engin
vaccin
provid
stronger
protect
provid
natur
infect
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
si
use
simul
dynam
infect
give
us
insight
interact
give
rise
tradeoff
observ
attenu
variou
immuneevas
pathway
viru
virus
attenu
evad
innat
immun
number
way
term
paramet
model
attenu
innat
immun
occur
chang
paramet
z
rate
innat
immun
stimul
v
sensit
innat
immun
recogn
viru
z
rate
wane
innat
immun
k
z
rate
constant
kill
viru
innat
immun
sensit
innat
immun
increas
reduc
viru
densiti
innat
immun
trigger
v
rate
innat
immun
stimul
z
seen
fig
scenario
find
signific
reduct
patholog
small
reduct
level
adapt
immun
gener
reason
seen
repres
simul
shown
fig
b
see
rapid
gener
innat
respons
result
rapid
control
clearanc
viru
innat
immun
adapt
immun
respons
need
viru
clearanc
find
durat
infect
significantli
affect
consequ
amount
adapt
immun
gener
substanti
thu
chang
two
paramet
lead
reduct
level
patholog
smaller
reduct
gener
immun
anoth
way
viru
also
evad
innat
immun
increas
rate
decay
innat
immun
z
seen
fig
vaccin
strain
viru
counter
reduc
rate
decay
innat
immun
reduc
extent
patholog
interestingli
gener
immun
elicit
wildtyp
vaccin
strain
caus
seen
fig
find
reduct
z
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
result
larger
longer
innat
respons
respons
control
viru
lower
densiti
longer
durat
respons
increas
stimul
adapt
immun
respons
final
way
consid
evas
innat
immun
decreas
rate
innat
immun
kill
viru
vaccin
strain
viru
increas
suscept
innat
immun
lower
patholog
lower
immun
seen
fig
fig
show
caus
viru
rapidli
control
result
lower
level
innat
immun
less
stimul
adapt
immun
virus
attenu
evad
adapt
immun
number
way
term
paramet
model
attenu
adapt
immun
occur
chang
paramet
x
maximum
rate
growth
adapt
immun
z
sensit
stimul
adapt
immun
recogn
viru
z
k
x
rate
constant
kill
viru
adapt
immun
seen
fig
chang
viru
increas
rate
prolifer
adapt
immun
either
increas
rate
prolifer
immun
cell
x
increas
sensit
immun
cell
stimul
v
result
attenu
less
patholog
higher
level
immun
reason
seen
fig
see
increas
x
decreas
v
result
faster
earlier
growth
adapt
immun
case
rapid
gener
adapt
immun
result
earlier
clearanc
pathogen
curtail
innat
immun
stimul
adapt
immun
though
decreas
v
extent
compens
case
innat
immun
increas
rate
clearanc
viru
adapt
immun
lead
rapid
clearanc
viru
caus
decreas
patholog
also
decreas
extent
stimul
final
level
adapt
immun
see
fig
ccbync
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
